Hua Medicine Is A Drug Development And Commercialization Company Based In Shanghaichinawith Additional Operations In The United States And Hong Kongthe Company Is Dedicated To Addressing Global Medical Needsparticularly In Diabetes Carethrough Innovative Therapies And A Patient Focused Approach The Flagship Producthuatangningdorzagliatin Tabletshms5552 Is Designed To Improve Glucose Sensitivity In Type 2 Diabetes Patientsapproved By China S National Medical Products Administration In September 2022It Can Be Used Alone Or In Combination With Metforminincluding For Patients With Chronic Kidney Disease Without The Need For Dose Adjustmentshua Medicine Has Made Significant Strides In Clinical Developmentincluding Successful Phase Ii Iii Trials And Ongoing Research To Further Understand The Drug S Mechanisms With A Commitment To Global Innovationhua Medicine Is Expanding Its Geographic Presence And Enhancing Its Leadership Team To Strengthen Its Market Positionthe Company Is Listed On The Hong Kong Stock Exchange And Is Focused On Commercializing Huatangning While Advancing Its Pipeline Of Diabetes Care Solutions
